HuagongsheHuagongshe Chemistry Print Report · For research reference only
Morpholine → 3-(1-{[3-(4-morpholinyl)propyl]sulfonyl}-4-piperidinyl)-5-(3-thienyl)-1H-indazole-7-carboxamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | HCID 178513564 | HCID 178513564 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 3-(1-{[3-(4-morpholinyl)propyl]sulfonyl}-4-piperidinyl)-5-(3-thienyl)-1H-indazole-7-carboxamide | HCID 178513566 | 8.9% |
Reaction Steps
The title compound was prepared according to the general procedure of Example 38b. Thus, 3-{1-[(3-chloropropyl)sulfonyl]-4-piperidinyl}-5-(3-thienyl)-1H-indazole-7-carboxamide (Example 48a) (0.05 mmol) in DMF (2 mL) was reacted with K2CO3 (14 mg, 0.1 mmol), triethyl amine (42 uL, 0.3 mmol) and morpholine (22 uL, 0.25 mmol) to afford the title compound (2.3 mg, 8.8%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08501780B2 |
| Source dataset | uspto-grants-2013_08 |
| ORD ID | ord-c1a4e89974a045eb8ace9e0213673bad |
| Source note | uspto-grants-2013_08 |